Results 111 to 120 of about 1,916 (204)

UEG Week 2024 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 12, Issue S8, Page 665-1360, October 2024.
wiley   +1 more source

Transcriptomic signatures of individual cell types in cerebral cavernous malformation

open access: yesCell Communication and Signaling
Cerebral cavernous malformation (CCM) is a hemorrhagic neurovascular disease with no currently available therapeutics. Prior evidence suggests that different cell types may play a role in CCM pathogenesis.
Ying Li   +20 more
doaj   +1 more source

Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation [PDF]

open access: yes
Cerebral cavernous malformation (CCM) is a neurovascular disease with symptoms such as strokes, hemorrhages and neurological deficits. With surgery being the only treatment strategy, understanding the molecular mechanisms of CCM is crucial in finding ...
Daniel, Geoffrey, Fernando, Dinesh
core  

Genetics and Molecular Biology of Cerebral Cavernous Malformations and CCM Italia

open access: yes, 2012
Loss-of-function mutations of the KRIT1 gene (CCM1) have been associated with the pathogenesis of Cerebral Cavernous Malformations (CCM), a major cerebrovascular disease characterized by abnormally enlarged and leaky capillaries that predispose to seizures, focal neurological deficits, and fatal intracerebral haemorrhage.
openaire   +1 more source

The effect of statins on the risk of bleeding in cerebral cavernous malformations: A systematic review and meta-analysis. [PDF]

open access: yesSurg Neurol Int
Erel BC   +10 more
europepmc   +1 more source

Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo. [PDF]

open access: yesJ Am Heart Assoc
Ali B   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy